| 依达拉奉联合血塞通治疗急性脑梗死的临床观察 |
| |
| 引用本文： | 张晓华,王斌.依达拉奉联合血塞通治疗急性脑梗死的临床观察[J].实用全科医学,2010,8(4):415-416. |
| |
| 作者姓名： | 张晓华 王斌 |
| |
| 作者单位： | 张晓华,ZHANG Xiao-hua(安徽省蚌埠医学院第一附属医院老年病科,233004);王斌,WANG Bin(蚌埠医学院临床一系2005级) |
| |
| 摘 要： | 目的观察依达拉奉联合血塞通治疗急性脑梗死的临床疗效及其安全性。方法将收治的急性脑梗死患者76例随机分为治疗组（39例）和对照组（37例）,对照组使用血塞通等常规治疗,治疗组在对照组治疗基础上,给予依达拉奉30mg加生理盐水100ml静脉滴注,2次/d,共14d。所有病例于治疗前和治疗14d后采用美国国立卫生研究院卒中量表（NIHSS）进行神经功能缺损评分。结果治疗后治疗组的神经功能缺损评分明显低于对照组,治疗组临床疗效明显优于对照组,两组比较差异有统计学意义（P〈0.05）。结论血塞通联合依达拉奉治疗急性脑梗死更安全有效,能改善患者的预后。
|
| 关 键 词： | 急性脑梗死 依达拉奉 血塞通 |
Clinical Therapeutic Effects and Safety of Recombinant Edarevone Combined with Xuesaitong on Acute Cerebral Infaction |
| |
| ZHANG Xiao-hua,WANG Bin.Clinical Therapeutic Effects and Safety of Recombinant Edarevone Combined with Xuesaitong on Acute Cerebral Infaction[J].Applied Journal Of General Practice,2010,8(4):415-416. |
| |
| Authors: | ZHANG Xiao-hua WANG Bin |
| |
| Affiliation: | ZHANG Xiao-hua,WANG Bin.Department of Gerontology,the First Affiliated Hospital of Bengbu Medical College,Bengbu 233004,Anhui,China |
| |
| Abstract: | Objective To study the clinical therapeutic effects and safety of recombinant Edarevone combined with Xuesaitong on acute cerebral infaction(ACI).Methods Seventy-nine patients with ACI were randomly divided into trial group(n=39) and control group(n=37).The control group were treated with Xuesaitong and neural protection etc.Additionally the patients in trial group were given Edaravone injection each 30 mg,dissolved in 100 ml of 0.9% sodium chloride solution administered by intravenous instillation bid for ... |
| |
| Keywords: | Acute cerebral Infaction Edaravone Xuesaitong |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
